131 related articles for article (PubMed ID: 30414472)
1. Integrated Bioinformatics Analysis for Identificating the Therapeutic Targets of Aspirin in Small Cell Lung Cancer.
Gong L; Zhang D; Dong Y; Lei Y; Qian Y; Tan X; Han S; Wang J
J Biomed Inform; 2018 Dec; 88():20-28. PubMed ID: 30414472
[TBL] [Abstract][Full Text] [Related]
2. The targets of aspirin in bladder cancer: bioinformatics analysis.
Li X; Tai Y; Liu S; Gao Y; Zhang K; Yin J; Zhang H; Wang X; Li X; Zhang D; Zhang DF
BMC Urol; 2022 Oct; 22(1):168. PubMed ID: 36316768
[TBL] [Abstract][Full Text] [Related]
3. [Bioinformatic analysis of direct protein targets of aspirin against human breast cancer proliferation].
Zhu X; Yang J; Zhang E; Qiao W; Li X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Oct; 39(10):1141-1148. PubMed ID: 31801720
[TBL] [Abstract][Full Text] [Related]
4. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer.
Lin MW; Su KY; Su TJ; Chang CC; Lin JW; Lee YH; Yu SL; Chen JS; Hsieh MS
Lung Cancer; 2018 Nov; 125():282-290. PubMed ID: 30429033
[TBL] [Abstract][Full Text] [Related]
6. A genetic snapshot of small cell lung cancer.
Rosell R; Wannesson L
Cancer Discov; 2012 Sep; 2(9):769-71. PubMed ID: 22969115
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer.
Shibata T; Kokubu A; Tsuta K; Hirohashi S
Cancer Lett; 2009 Oct; 283(2):203-11. PubMed ID: 19394761
[TBL] [Abstract][Full Text] [Related]
8. Integration of protein phosphorylation, acetylation, and methylation data sets to outline lung cancer signaling networks.
Grimes M; Hall B; Foltz L; Levy T; Rikova K; Gaiser J; Cook W; Smirnova E; Wheeler T; Clark NR; Lachmann A; Zhang B; Hornbeck P; Ma'ayan A; Comb M
Sci Signal; 2018 May; 11(531):. PubMed ID: 29789295
[TBL] [Abstract][Full Text] [Related]
9. Bromodomain and hedgehog pathway targets in small cell lung cancer.
Kaur G; Reinhart RA; Monks A; Evans D; Morris J; Polley E; Teicher BA
Cancer Lett; 2016 Feb; 371(2):225-39. PubMed ID: 26683772
[TBL] [Abstract][Full Text] [Related]
10. Identification of Key Potential Targets and Pathway for Arsenic Trioxide by Systemic Bioinformatics Analysis in Pancreatic Cancer.
Pang Y; Liu Z; Liu S
Pathol Oncol Res; 2019 Apr; 25(2):681-690. PubMed ID: 30506130
[TBL] [Abstract][Full Text] [Related]
11. Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer.
Suda K; Murakami I; Sakai K; Mizuuchi H; Shimizu S; Sato K; Tomizawa K; Tomida S; Yatabe Y; Nishio K; Mitsudomi T
Sci Rep; 2015 Sep; 5():14447. PubMed ID: 26400668
[TBL] [Abstract][Full Text] [Related]
12. Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression.
Polley E; Kunkel M; Evans D; Silvers T; Delosh R; Laudeman J; Ogle C; Reinhart R; Selby M; Connelly J; Harris E; Fer N; Sonkin D; Kaur G; Monks A; Malik S; Morris J; Teicher BA
J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27247353
[TBL] [Abstract][Full Text] [Related]
13. Personalized Therapy of Small Cell Lung Cancer.
Schneider BJ; Kalemkerian GP
Adv Exp Med Biol; 2016; 890():149-74. PubMed ID: 26703804
[TBL] [Abstract][Full Text] [Related]
14. Ganetespib for small cell lung cancer.
Subramaniam DS; Warner EA; Giaccone G
Expert Opin Investig Drugs; 2017 Jan; 26(1):103-108. PubMed ID: 27922280
[TBL] [Abstract][Full Text] [Related]
15. Small-cell lung cancer: an update on targeted therapies.
Joshi M; Ayoola A; Belani CP
Adv Exp Med Biol; 2013; 779():385-404. PubMed ID: 23288650
[TBL] [Abstract][Full Text] [Related]
16. [Molecular targeted therapies in small-cell lung cancer].
Levy A; Malouf GG; Besse B; Massard C; Soria JC
Bull Cancer; 2010 May; 97(5):535-45. PubMed ID: 20093224
[TBL] [Abstract][Full Text] [Related]
17. Small cell lung cancer: will recent progress lead to improved outcomes?
Pietanza MC; Byers LA; Minna JD; Rudin CM
Clin Cancer Res; 2015 May; 21(10):2244-55. PubMed ID: 25979931
[TBL] [Abstract][Full Text] [Related]
18. Overcoming Chemotherapy Resistance in SCLC.
Herzog BH; Devarakonda S; Govindan R
J Thorac Oncol; 2021 Dec; 16(12):2002-2015. PubMed ID: 34358725
[TBL] [Abstract][Full Text] [Related]
19. Genetic alterations and protein expression in combined small cell lung cancers and small cell lung cancers arising from lung adenocarcinomas after therapy with tyrosine kinase inhibitors.
Shi X; Duan H; Liu X; Zhou L; Liang Z
Oncotarget; 2016 Jun; 7(23):34240-9. PubMed ID: 27145273
[TBL] [Abstract][Full Text] [Related]
20. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.
Rekhtman N; Pietanza MC; Hellmann MD; Naidoo J; Arora A; Won H; Halpenny DF; Wang H; Tian SK; Litvak AM; Paik PK; Drilon AE; Socci N; Poirier JT; Shen R; Berger MF; Moreira AL; Travis WD; Rudin CM; Ladanyi M
Clin Cancer Res; 2016 Jul; 22(14):3618-29. PubMed ID: 26960398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]